The methodological and reporting quality of randomized controlled trials of tyrosine kinase inhibitors for advanced differentiated thyroid cancer: Meta-research study.
Rogerio Aparecido DedivitisMario Augusto Ferrari de CastroAlice Matos Dal BoniAna Carolina Beltrão AlvaresAna Júlia Piazentin TressoAndrea Davedovicz de OliveiraAmanda Gonçalves da Silva Dourado VieiraFernanda Assaf MendesGiovana de Oliveira RossiGiullia Neworal FavaIsabela Santos PouzaIzabelle Pimenta SantanaJulia Gibran LainoLetícia Barbosa de LimaAna Luiza Cabrera MartimbiancoPublished in: Head & neck (2024)
Overall, the assessed RCTs were predominantly at low risk of bias. The critical evaluation of these studies is essential to have confidence in the treatment estimated effect that will support clinical decision-making and provide information to preclude future clinical study flaws.